Amwill Health CareShare price, financial results, shareholding and management
- Market cap
- ₹88 cr
- Stock P/E
- 7.7peers 21.9
- Book value
- ₹40.5
- Price to book
- 1.09
- EV / operating profit
- -
- Market cap to sales
- 1.93
- ROCE · FY26
- 20.5%
- ROE · FY26
- 15.2%
- ROE, 3-year average
- 49.6%
- Operating margin · FY26
- 28.6%peers 17.2%
- Sales growth, 3 years
- 17.6%
- Profit growth, 3 years
- 56.1%
- Debt to equity
- 0.00peers 0.39
- Borrowings
- ₹0 cr
- Interest cover
- No interest
- Cash from business / op. profit
- 62%
- Debtor days
- 177
- Pledged
- 0.00%
- Promoter holding
- 70.65%
- Change in promoter holding
- 0.00 pts
- Shareholders
- 1,483
- 52-week high / low
- ₹50 / ₹29
- Dividend yield
- Paid
- Face value
- ₹10
Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.
newboard is reading this company's filings. Its plain description, key points, management and study will appear here soon; the figures below are worked out from what it has filed.
Amwill Health Care share price chart
Close on 6 Nov 2026 · +5.67% on the day · Vol 15,600
Daily prices to 6 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.
Share price returns
To the close of 6 Nov 2026
- 1 month
- +2.4%
- 3 months
- +6.0%
- 6 months
- +26.1%
- 1 year
- -6.7%
- Traded a day, 20 days
- ₹0.06 cr
Business growth
Sales and net profit, from the reported results
| Sales | Profit | |
|---|---|---|
| FY26 on FY25 | +12% | +6% |
| 3 years, a year | +18% | +56% |
| Latest half, H2 FY26 | +39% | +79% |
Amwill Health Care revenue and profit growth
Half-yearly results · Profit and lossSales have grown steadily. Last year profit grew more slowly than sales, so the profit kept from each rupee of sales slipped.
SME companies report every six months. In the latest half, sales were higher than in the same half a year before. Profit grew faster than sales.
Amwill Health Care half-yearly results
SME companies report every six months · ₹ crore
| H1FY25 | H2FY25 | H1FY26 | H2FY26 | |
|---|---|---|---|---|
| Sales | 23 | 17.43 | 21.20 | 24.29 |
| Expenses | 14 | 14.61 | 17.10 | 15.40 |
| Operating profit | 9 | 2.81 | 4.11 | 8.88 |
| OPM | 38.0% | 16.1% | 19.4% | 36.6% |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0.27 | 0.24 | 0.30 |
| Profit before tax | 9 | 3.15 | 5.26 | 10.10 |
| Net profit | 7 | 4.21 | 3.87 | 7.55 |
Amwill Health Care profit and loss
Full years to March, FY21 to FY26 · ₹ crore, consolidated where reported
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Sales | 17 | 26 | 28 | 42 | 40.58 | 45.49 |
| Expenses | 18 | 22 | 24 | 25 | 28.93 | 32.50 |
| Operating profit | -1 | 4 | 4 | 17 | 11.65 | 12.99 |
| OPM | -6.0% | 14.0% | 15.0% | 40.0% | 28.7% | 28.6% |
| Other income | 0 | 0 | 0 | 0 | 0.71 | 2.92 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0.46 | 0.55 |
| Exceptional and other items | · | -1 | · | · | · | · |
| Profit before tax | -1 | 3 | 4 | 17 | 11.90 | 15.37 |
| Tax rate | -3.0% | 0.0% | 25.0% | 29.4% | 9.8% | 25.7% |
| Net profit | -1 | 3 | 3 | 12 | 10.73 | 11.42 |
| EPS ₹ | -333.33 | 856.67 | 1,037 | 2,500 | 6.63 | 5.71 |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 9.0% |
The years to FY24 come rounded to the nearest crore in the source.
Exceptional and other items: profit before tax beyond operating profit, other income, interest and depreciation, such as one-off items or a share of associates' profit, as reported.
A tax rate above 60% or below zero (FY21) comes from tax charged on a small or negative profit, as reported.
Earnings per share before FY25 is on the share count of that time, before later bonus or share issues, so it does not compare with the years after.
Amwill Health Care profitability
Margins and returns on capitalLast year the company kept about as much from each rupee of sales as the year before. It earns a high return on the money it uses.
Operating margin, every year
Per cent of sales kept before interest, depreciation and tax
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Operating margin | -6.0% | 14.0% | 15.0% | 40.0% | 28.7% | 28.6% |
| Tax rate | -3.0% | 0.0% | 25.0% | 29.4% | 9.8% | 25.7% |
| ROCE | · | · | 132.0% | 154.0% | 27.7% | 20.5% |
| ROE | · | · | 99.0% | 108.7% | 24.9% | 15.2% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 9.0% |
Amwill Health Care debt and cash flow
Balance sheet · Cash flow · Working capitalThe company's own money, its net worth, has grown. It has almost no borrowings. Last year the business brought in less cash than it showed as profit, so part of the profit is still to be collected. Customers take longer to pay than they did in FY24, which ties up more of the company's money in unpaid bills.
Bars below the line are cash going out.
Amwill Health Care balance sheet
At each 31 March · ₹ crore
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Equity capital | 0.03 | 0.03 | 0.03 | 0.05 | 20 | 20 |
| Reserves | -1 | 1 | 5 | 17 | 49 | 61 |
| Net worth | -0.97 | 1.03 | 5.03 | 17.05 | 69 | 81 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Other liabilities | 8.97 | 5.97 | 6.97 | 1.95 | 2 | 6 |
| Total liabilities | 8 | 7 | 12 | 19 | 71 | 87 |
| Fixed assets | 1 | 0 | 1 | 1 | 1 | 1 |
| Capital work in progress | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 3 |
| Other assets | 7 | 7 | 11 | 17 | 70 | 83 |
Amwill Health Care cash flow
₹ crore
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Cash from operations | 0 | 3 | 5 | -3 | 6 | 8 |
| Cash from investing | -1 | 0 | -1 | -1 | -46 | 6 |
| Cash from financing | 0 | 0 | 0 | 0 | 41 | 0 |
| Net cash flow | -1 | 3 | 4 | -4 | 1 | 14 |
Working capital
Days
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Debtor days | 93 | 12 | 16 | 114 | 163 | 177 |
| Inventory days | · | · | · | 66 | · | · |
| Days payable | · | · | · | 39 | · | · |
| Cash conversion cycle | 93 | 12 | 16 | 141 | 163 | 177 |
| Working capital days | -45 | -25 | -38 | 111 | 166 | 158 |
Amwill Health Care peers and competitors
Listed SME companies in the same industryBy sales, Amwill Health Care is number 24 of the 34 listed SME companies in pharmaceuticals & biotechnology.
Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.
| Company | Market cap ₹ cr | P/E | Sales ₹ cr | Profit ₹ cr | Op. margin | Debt/equity |
|---|---|---|---|---|---|---|
| Curis Lifesciences | 154 | 22.3 | 60.6 | 6.9 | 18.4% | 0.46 |
| Aptus Pharma | 779 | 168.7 | 46.6 | 4.6 | 16.0% | 0.31 |
| Amwill Health Care | 88 | 7.7 | 45.5 | 11.4 | 28.6% | 0.00 |
| Bio Medica Laboratories | 205 | 17.4 | 43.1 | 11.8 | 45.6% | 1.51 |
| Himalaya Nutravedics India | 127 | 17.1 | 43.1 | 7.4 | 18.8% | 0.31 |
| Vilin Bio Med | 79 | 41.1 | 42.3 | 1.9 | 7.6% | 0.01 |
| Accretion Nutraveda | 214 | 42.1 | 33.6 | 5.1 | 20.5% | 0.12 |
| Goldline Pharmaceutical | 30 | 7.4 | 31.2 | 4.1 | 22.7% | 0.88 |
| Cian Healthcare | 67 | - | 28 | -23 | -24.0% | 3.22 |
| Asston Pharmaceuticals | 83 | 21.5 | 25.5 | 3.9 | -2.0% | 0.13 |
| Medicamen Organics | 39 | - | 22.6 | -4 | -16.6% | 0.50 |
| Median of the 10 others | 105 | 21.9 | 37.9 | 4.4 | 17.2% | 0.39 |
Amwill Health Care shareholding pattern
Promoters, FIIs, DIIs, HNIs and small holdersThe promoters own more than half the company. Big foreign and Indian funds own very little. The number of shareholders is about the same.
Amwill Health Care shareholding pattern
Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.
| Mar 25 | Sep 25 | Mar 26 | |
|---|---|---|---|
| Promoters | 70.65% | 70.65% | 70.65% |
| Foreign investors (FIIs) | 1.16% | 1.16% | - |
| Number of shareholders | 1,374 | 1,606 | 1,483 |
Amwill Health Care latest news and announcements
Announcements · Documents · Corporate actionsWhat changed recently
Each half-year is set against the same half a year earlier
- H2 FY26: sales ₹24.3 cr (+39%), net profit ₹7.6 cr (+79%) on H2 FY25.
- Shareholding, 31 March 2026: promoters unchanged at 70.65%.
Amwill Health Care announcements
3 on record, latest first; each opens the filing on the exchange
- Company UpdateIntimation under Regulation 30 of the Sebi (listing Obligation and disclosure Requirements) Regulations,2015- Grant of license/regulatory approval for import ofPDF ↗
- Company UpdateCertificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the 2nd Quarter ended September 30, 2026 of FY 2026-27PDF ↗
- Insider Trading / SASTIntimation of Trading Window Closure for Half Year ending September 30, 2026PDF ↗
Amwill Health Care annual reports, earnings calls and documents
Every document links to its source; “read” marks those this page is built from
Amwill Health Care share split, bonus and dividends
From the corporate actions the company announces on the exchange
- DividendFinal Dividend - Rs. - 0.5000ex-date 7 Aug 2026
Checks we ran on Amwill Health Care's data · 9
Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.
- iOn 2 Feb 2026 the exchange restated the previous close by a factor of 0.873 (a split, bonus or rights issue); earlier prices on this page are put on the new basis.
- ✓Balance sheet totals add up for FY25 and FY26.
- ✓Market cap uses the share count in the latest shareholding pattern (2,00,03,600 shares).
- ✓The share capital in the FY26 results matches the share count in the shareholding pattern.
- ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
- ✓The two half-years of FY26 add up to the full-year sales.
- !Earnings per share changes basis between FY24 (₹2,500.00) and FY25 (₹6.63) because the share count behind it changes; EPS is shown as reported, and growth is worked out on profit.
- ✓Revenue and profit are reported for every year shown, FY21 to FY26.
- iPrices run to the close on 14 Oct 2026, from the exchange's daily figures.
Questions people ask about Amwill Health Care
What does Amwill Health Care do?
Amwill Health Care is an SME company listed on BSE SME, in pharmaceuticals & biotechnology.
What is the share price of Amwill Health Care?
₹44 at the close on 6 Nov 2026, from the exchange's daily figures.
What is the market cap of Amwill Health Care?
₹88 cr at the close on 6 Nov 2026, on 2,00,03,600 shares.
What is the P/E of Amwill Health Care?
7.7 times FY26 profit at the close on 6 Nov 2026 (our arithmetic).
What are Amwill Health Care's revenue and profit?
Revenue ₹45 cr and profit after tax ₹11 cr in FY26.
Who are the promoters of Amwill Health Care?
The promoter group; promoters held 70.65% at 31 March 2026.
What is Amwill Health Care's website?
www.amwillhealthcare.com
More SME companies like Amwill Health Care
Other listed SME companies in pharmaceuticals & biotechnology, the closest in size first, each read from its own documents.
- Cian HealthcareCHCL · BSE SME · Pharmaceuticals & BiotechnologyMarket cap ₹91 cr
- Vilin Bio MedVILINBIO · NSE Emerge · Pharmaceuticals & Biotechnology · listed 2023Market cap ₹83 cr
- Shelter PharmaSHELTER · BSE SME · Pharmaceuticals & BiotechnologyMarket cap ₹79 cr
- Zenith DrugsZENITHDRUG · NSE Emerge · Pharmaceuticals & Biotechnology · listed 2024Market cap ₹66 cr
- Asston PharmaceuticalsAPL · BSE SME · Pharmaceuticals & BiotechnologyMarket cap ₹120 cr
- Onyx BiotecONYX · NSE Emerge · Pharmaceuticals & Biotechnology · listed 2024Market cap ₹63 cr
Every listed SME company in Pharmaceuticals & Biotechnology →
Built from 3 exchange announcements, 3 shareholding patterns and 6 years of reported results. Every figure carries its source; where the documents are silent, the page says so.